Benchmark Announces Appointment of Independent Director

0
24

Vancouver, British Columbia–(Newsfile Corp. – November 17, 2020) –  Benchmark Botanics, Inc. (CSE: BBT) (FSE: BBW) (“Benchmark” or the “Company“) is pleased to announce the appointment of Mr. Mike Cosic to the Company’s board of directors.

Mr. Cosic brings over 25 years of financial experience to Benchmark Botanics, including corporate finance and corporate development involving several mergers, acquisitions and divestitures. He is currently the CFO of Meta Growth Corp., a leading Canadian recreational cannabis retailer. He was previously the CFO at both DLT Labs Inc. and Lithium Americas Corp., and currently sits on the Board of Directors and is Audit Committee Chairman of Eastern Platinum Limited. Mr. Cosic holds an MBA degree and is a CFA charterholder.

About Benchmark

Benchmark is a diversified multi-licensed cannabis producer focused on a three-way vertical business model targeting the medical and recreational markets in Canada. The Company’s business plan also includes a strategy to become a Canadian licensed producer to pioneer selling medical cannabis and hemp throughout Asia, in countries where it is legal to do so.

Benchmark is focused on producing the highest-quality, indoor-grown cannabis for patients and adult recreational consumers, as well as developing international business partnerships to extend the Company’s global footprint.

Benchmark’s 100% owned subsidiary, Potanicals Green Growers Inc. (“Potanicals”) is a Health Canada licensed producer under the Cannabis Act and its regulations. The Company has been producing at its indoor Peachland, BC Cannabis Complex. Along with cultivation and production, the Company’s Peachland BC facility also provided propagation, cultivation, cloning, storage, and research and development including genetic enhancements.

As part of its expansion strategy, the Company and a joint venture partner completed a second facility, a 4-acre Greenhouse Operation in Pitt Meadows, BC. The Company, through Potanicals, received its second cultivation license, effective November 29, 2019, from Health Canada for the Pitt Meadow greenhouse.

For further information, please visit the Company’s website at www.benchmarkbotanics.com or the Company’s profile at www.sedar.com.

If you would like to be added to Benchmark’s news distribution list, please sign up at Investor Relations info@bbtinc.ca

ON BEHALF OF THE BOARD OF
BENCHMARK BOTANICS INC.

“William Ying”
William Ying
Chief Executive Officer

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this release.

Forward-Looking Statements

This news release contains forward-looking statements pertaining to various risks and uncertainties regarding future events. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Actual results could differ materially from those currently anticipated due to a number of factors and risks including the risk factors discussed in this news release and in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com and on the CSE website. These statements speak only as of the date of this news release. Except as required by law, the Company does not intend to update these forward-looking statements.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/68376

LEAVE A REPLY

Please enter your comment!
Please enter your name here